Biotech · Private company · Cambridge, MA, US

Xgenomes Corp.

Track this companyFree. Adds Xgenomes Corp. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

A novel ctDNA analysis solution for the next-generation of liquid biopsy assaysFiscal year 2025 · $399.8KNIH RePORTER 1R43CA295403-01A1 · fetched Nov 12, 2026
Achieving ultra-high-density, ultra-high-precision single molecule localization microscopy with whole-video deep learning architecturesFiscal year 2025 · $349.3KNIH RePORTER 1R43GM157889-01A1 · fetched Nov 12, 2026
Sequencing of epigenetic modifications across the genome by single-molecule detection of oligonucleotide binding kineticsFiscal year 2025 · $397.6KNIH RePORTER 1R43HG013914-01A1 · fetched Nov 12, 2026
Super-resolution single-molecule sequencing by observing the dynamic hybridization of a repertoire of oligonucleotides to DNA targetsFiscal year 2024 · $384.4KNIH RePORTER 1R43HG013911-01 · fetched Nov 12, 2026